K-beauty glass-skin trend exposes safety gaps in viral skin care
Almost all viral TikTok videos about the “glass skin” trend that K-beauty popularized contain misleading claims, according to a new study. The researchers found that 95% of these videos included at least one potentially misleading claim, and basic safety information was also largely missing.
EU looks to speed agricultural research to market despite budget pressures
Scientists, policy experts, NGOs and farmers gathered in Brussels Thursday and Friday to tackle a tough question: How ca…
The $100 Billion Leak in Africa’s Food System
5 For all its potential, Africa still faces a curious contradiction. It has the fertile land, the young workforce and th…
China to lower tariffs on US cosmetics as trade truce extends
China and the US have said they will cut tariffs on US$60 billion worth of goods imported from each other. The announcement encompasses US cosmetics and Chinese hair-removal appliances, among others.
Genmab’s Phase 2 data strengthens case for $1.8B ProfoundBio bet
Why it matters: Genmab has already dropped or deprioritized several earlier-stage antibody-drug conjugates (ADCs) acquired from ProfoundBio. Rina-S is increasingly carrying the burden of proving that the 2024 acquisition was worth its price. Fortunately for the Danish company, the latest data strengthen that case.
🎥 Atmonia scales green ammonia with single-step electrochemical process
Ammonia is essential to modern agriculture, but making it via the traditional Haber-Bosch process is carbon-intensive an…
TRAFFIC tackles beauty’s wild-harvest sourcing risks with framework
TRAFFIC (Trade Record Analysis of Flora and Fauna in Commerce) and Biodiversify have launched the Wild Harvest Improvement Project (WHIP) Framework to improve the sustainability of wild-harvested feedstocks, also used in personal care formulations.
AgriFood Signals: Corteva & Inari settle, Starbucks scales back green goals, countries rethink climate reporting
AgFunderNews rounds up the most important fundings, mergers, acquisitions, closures, and industry buzz in agtech and foo…
Novartis bets up to $7.8B on Abogen’s mRNA autoimmune therapy
Why it matters: The approach could offer a simpler way to target the B cells that drive some autoimmune diseases. It aims to achieve deep B-cell depletion without collecting and engineering patients’ immune cells, as conventional CAR-T therapies require.
Pharming changes CEO, Evotec loses CSO and Nanobiotix hires CFO
Pharming: CEO exits after strategic disagreement. Fabrice Chouraqui stepped down on September 29 after he and the company’s board concluded that their views on executing the Dutch biotech’s strategy were not sufficiently aligned. Chief Commercial Officer Leverne Marsh and Chief Financial Officer Kenneth Lynard became interim co-CEOs while the board searches for a successor. Go deeper.
